VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 140 filers reported holding VIKING THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,439,422 | -25.0% | 2,026,788 | +9.8% | 0.00% | -25.0% |
| Q2 2023 | $29,930,786 | +108.2% | 1,846,439 | +113.9% | 0.00% | +100.0% |
| Q1 2023 | $14,372,824 | +233604.5% | 863,232 | +31.9% | 0.00% | +100.0% |
| Q4 2022 | $6,150 | -99.7% | 654,306 | +0.2% | 0.00% | – |
| Q3 2022 | $1,776,000 | -10.3% | 653,037 | -4.8% | 0.00% | – |
| Q2 2022 | $1,981,000 | -48.9% | 685,749 | -46.9% | 0.00% | – |
| Q1 2022 | $3,876,000 | -28.7% | 1,292,267 | +9.4% | 0.00% | -100.0% |
| Q4 2021 | $5,435,000 | -27.1% | 1,181,655 | -0.5% | 0.00% | 0.0% |
| Q3 2021 | $7,456,000 | +7.3% | 1,187,322 | +2.3% | 0.00% | 0.0% |
| Q2 2021 | $6,950,000 | +3.2% | 1,160,325 | +9.0% | 0.00% | 0.0% |
| Q1 2021 | $6,733,000 | +22.8% | 1,064,624 | +9.3% | 0.00% | 0.0% |
| Q4 2020 | $5,481,000 | -0.7% | 973,688 | +2.6% | 0.00% | 0.0% |
| Q3 2020 | $5,522,000 | -21.9% | 948,798 | -3.3% | 0.00% | -50.0% |
| Q2 2020 | $7,073,000 | +56.3% | 981,029 | +1.5% | 0.00% | +100.0% |
| Q1 2020 | $4,525,000 | -68.9% | 966,914 | -46.8% | 0.00% | -50.0% |
| Q4 2019 | $14,572,000 | +168.9% | 1,817,030 | +130.6% | 0.00% | +100.0% |
| Q3 2019 | $5,420,000 | -11.8% | 787,851 | +6.4% | 0.00% | 0.0% |
| Q2 2019 | $6,144,000 | -8.2% | 740,301 | +9.9% | 0.00% | -50.0% |
| Q1 2019 | $6,692,000 | -26.4% | 673,320 | -43.4% | 0.00% | +100.0% |
| Q4 2018 | $9,096,000 | +14.7% | 1,189,020 | +161.3% | 0.00% | -50.0% |
| Q3 2018 | $7,927,000 | +110.9% | 455,090 | +14.9% | 0.00% | +100.0% |
| Q2 2018 | $3,758,000 | +267.4% | 396,011 | +69.0% | 0.00% | – |
| Q1 2018 | $1,023,000 | +114.5% | 234,314 | +99.2% | 0.00% | – |
| Q4 2017 | $477,000 | +708.5% | 117,619 | +276.2% | 0.00% | – |
| Q3 2017 | $59,000 | +78.8% | 31,264 | 0.0% | 0.00% | – |
| Q2 2017 | $33,000 | -26.7% | 31,264 | 0.0% | 0.00% | – |
| Q1 2017 | $45,000 | +21.6% | 31,264 | 0.0% | 0.00% | – |
| Q4 2016 | $37,000 | -15.9% | 31,264 | 0.0% | 0.00% | – |
| Q3 2016 | $44,000 | +12.8% | 31,264 | 0.0% | 0.00% | – |
| Q2 2016 | $39,000 | – | 31,264 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 250,000 | $2,005,000 | 5.90% |
| Sio Capital Management, LLC | 731,453 | $5,866,000 | 1.40% |
| KNOTT DAVID M | 218,102 | $1,749,000 | 0.71% |
| ArrowMark Colorado Holdings LLC | 8,813,578 | $70,685,000 | 0.63% |
| DAFNA Capital Management LLC | 209,200 | $1,678,000 | 0.58% |
| Park West Asset Management LLC | 1,545,075 | $12,391,000 | 0.52% |
| SPHERA FUNDS MANAGEMENT LTD. | 590,000 | $4,732,000 | 0.39% |
| Cornerstone Capital, Inc. | 245,796 | $1,971,000 | 0.28% |
| Ikarian Capital, LLC | 150,000 | $1,203,000 | 0.20% |
| Ikarian Capital, LLC | 150,000 | $1,203,000 | 0.20% |